Decent sized order being filled. Will take over 200k shares in one hit, and 9.81 being offered to sell up to 150k shares. Might well turn now. N/T to buy.
'Strong indications that Big Pharma will provide the necessary bispecific antibody,free of charge, for the Company’s proposed Phase 2a trial which is a significant validation as to industry interest in POLB 001 and its potential'
That's the key point for me - Big Pharma investment & involvement/interest.
RE: No Commerciality Until October Launch13 May 2025 16:03
Personally I'm less bothered about the short term commercial aspect of this. I'm more interested ,and impressed, by the fact that CPX have won, what would've been a competitive tender (likely against some big players), for a multinational conglomerate. Speaks volumes.